首页> 外文期刊>Oncology Research >miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line
【24h】

miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line

机译:miR-183调节舌鳞状细胞癌SCC25细胞系中的细胞凋亡和增殖。

获取原文
获取原文并翻译 | 示例
       

摘要

This study was designed to investigate the role of miR-183 in modulating cell growth and apoptosis of tongue squamous cell carcinoma SCC25 cell line. Human squamous epithelial cell and squamous cell carcinoma cell line SCC25 was used, and miR-183 was inhibited. Cell growth, colony formation, and apoptotic rate, as well as the expression of caspase 3 and BCL-xL, were detected. Results showed that miR-183 was significantly overexpressed in the SCC25 cell line when compared with normal control. The miR-183 inhibitor reduced cell growth and colony formation, while the apoptosis percentage was significantly increased. The expression of activated caspase 3 and BCL-xL was obviously up-and downregulated in siRNA-transfected cells, respectively. In conclusion, miR-183 contributed to cell growth and proliferation, and suppressed cell apoptosis in SCC25 cells. Therefore, miR-183 might serve as a therapeutic target in tongue squamous cell carcinoma (TSCC).
机译:本研究旨在研究miR-183在调节舌鳞状细胞癌SCC25细胞系细胞生长和凋亡中的作用。使用了人类鳞状上皮细胞和鳞状细胞癌细胞系SCC25,miR-183被抑制。检测细胞生长,集落形成和凋亡率,以及caspase 3和BCL-xL的表达。结果显示,与正常对照相比,miR-183在SCC25细胞系中显着过表达。 miR-183抑制剂可减少细胞生长和集落形成,而凋亡百分比则显着增加。在siRNA转染的细胞中,活化的胱天蛋白酶3和BCL-xL的表达分别明显上调和下调。总之,miR-183有助于细胞生长和增殖,并抑制SCC25细胞中的细胞凋亡。因此,miR-183可以作为舌鳞状细胞癌(TSCC)的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号